Logo
LUMIFIL L Kiss with Lidocaine – 1 x 1 ml

LUMIFIL L Kiss with Lidocaine – 1 x 1 ml

LUMIFIL

Dermal filler
  • LUMIFIL L Kiss is marketed as a CE Marked medical device in the EU/UK as part of the LUMIFIL dermal filler range.
  • Manufactured by BNC Korea under their regulated quality system; product undergoes purification and quality control to meet regulatory standards for HA fillers.
  • Use restricted to licensed medical professionals or trained aesthetic practitioners — in compliance with medical device and cosmetic regulations.
Cross-linked hyaluronic acid filler for lips and facial volumising with lidocaine

Description

LUMIFIL L-Kiss with Lidocaine is a premium cross-linked hyaluronic acid dermal filler supplied as a 1 ml pre-filled syringe, formulated for lip augmentation, volume restoration and contouring of facial areas. The filler uses high-density HA in a stable 3D gel with uniform particle structure (via patented particle / cross-linking technology) to ensure smooth injection, predictable moulding and long-lasting volume. Inclusion of lidocaine (0.3%) enhances patient comfort during injection. L-Kiss is aimed at practitioners seeking precise, controllable volume for lips, cheeks, chin, nasolabial folds and other areas depending on wrinkle severity and desired augmentation.

Bnefits

  • Ideal for lip augmentation and contouring — delivers fuller, defined lips with natural texture and shape.
  • High viscoelasticity and high-density HA (approx. 2,500,000 Da) for longer-lasting volume and structural support.
  • Uniform particle size and patented cross-linking / PP technology enabling smooth injection flow, easy moulding and minimal migration.
  • 0.3% lidocaine content reduces discomfort during injection for better patient tolerance.
  • Versatile — suitable not only for lips but also cheeks, chin, jawline, nasolabial folds and other facial areas requiring volume or structure.
  • Results reported to last typically 9–12 months, sometimes up to 12–18 months depending on area treated and patient factors.
  • CE-marked/following CE compliance (per distributor and manufacturer information) — supports regulatory compliance for clinical use.

Indications

  • Lip augmentation and enhancement (volume, definition, shape, cupid’s bow, border definition).
  • Facial volumisation in cheeks, chin, jawline for contouring and structural support where appropriate.
  • Correction of nasolabial folds and other moderate to deep facial lines or folds depending on area and filler viscosity needs.
  • General facial contouring and volume restoration as clinically indicated by a trained practitioner.

Composition

  • Cross-linked hyaluronic acid (HA), concentration 20 mg/ml.
  • Lidocaine hydrochloride 0.3% (3 mg/ml) for local anaesthesia and injection comfort.
  • Physiological buffer (phosphate-buffered saline) and sterile water vehicle; exact excipients per IFU.

Formulation

  • Monophasic, cross-linked hyaluronic acid gel with high viscoelasticity and uniform particle size (patented particle / PP process).
  • Pre-filled 1 ml sterile syringe intended for intradermal / mid-to-deep dermal or subcutaneous injection depending on area.
  • Contains 0.3% lidocaine to reduce discomfort during injection.

Packaging

  • 1 × 1 ml pre-filled sterile syringe per pack (single-use).
  • Typically supplied with two sterile needles (e.g. 27–30 G) depending on distributor — confirm at time of purchase.
  • Package includes batch number, expiry, and instructions for use as required for CE-marked devices.

Usage

  • For professional use only by trained and licensed healthcare or aesthetic practitioners.
  • Use aseptic technique: clean and disinfect the injection area; use sterile gloves and needles; avoid intravascular injection.
  • Select appropriate injection technique based on treatment area: small linear threads, serial puncture or micro-bolus for lips/contours; mid to deep dermal or superficial subcutaneous planes per area.
  • Inject slowly and evenly; after injection, mould gently if needed to achieve smooth, even contouring; avoid overfilling.
  • Post-procedure care: advise patient to avoid makeup, extreme heat/cold, strenuous activity, alcohol and sun exposure for 24–48 hours (or per clinic protocol); monitor for swelling/bruising and manage per standard aftercare. [not always explicitly listed but standard best practice for filler procedures]
  • Record batch number, lot, patient consent and procedure details in medical records as per professional and regulatory guidelines.

Contraindications

  • Known hypersensitivity or allergy to hyaluronic acid, lidocaine or any component of the filler formulation.
  • Active skin infection, inflammation, or disease at or near the intended injection site (e.g. acne flare, dermatitis, cold sores/herpes simplex).
  • History of severe allergic reactions, anaphylaxis or multiple allergies that makes elective injectables inadvisable.
  • Use in areas with previous permanent fillers or implants where interactions may occur, unless evaluated safe by the practitioner.
  • Pregnancy and breastfeeding — elective cosmetic filler use is generally avoided due to lack of safety data (common practice).
  • Any other contraindications or precautions specified in the official Manufacturer’s IFU or local regulations.

Adverse Effects

  • Common transient reactions: redness, swelling, bruising, tenderness or mild discomfort at the injection site; possible itching or mild induration.
  • Possible lumps, asymmetry or uneven result if injection or placement technique is suboptimal.
  • Risk of infection if aseptic technique is not strictly followed.
  • Rare but serious complications: intravascular injection leading to vascular occlusion, tissue ischaemia or necrosis, potential for prolonged inflammation or delayed hypersensitivity; need for hyaluronidase rescue protocols and emergency measures.
  • Patients should be informed to seek immediate medical attention in case of visual changes, persistent blanching, severe pain, discolouration, or signs of infection post-injection.

Storage Conditions

  • Store the product in its original packaging, at room temperature (e.g. 1–30 °C), protected from direct sunlight and freezing.
  • Keep out of reach of unauthorised persons and children; store in a secure, clean environment accessible only to qualified personnel.
  • Do not use if packaging is damaged, integrity compromised, the gel appears discoloured or contains particulates, or the product is past its expiration date.

Duration

Commonly reported effect duration is 9\u201312 months; some sources report up to 12\u201318 months depending on injection site, volume used, patient metabolism and lifestyle.

Onset

Volume enhancement and contouring are visible immediately after injection, with final settled results typically apparent after initial swelling subsides over a few days.

Browse more Dermal filler

Top Treatments

Top Cities in the UK